News | Breast Density | November 01, 2022

Onsite Women’s Health, Whiterabbit and Washington University in St. Louis Join Forces to Explore Breast Density and Implications for Breast Cancer Risk

Onsite Women’s Health, Whiterabbit and Washington University in St. Louis Join Forces to Explore Breast Density and Implications for Breast Cancer Risk

Getty Images


November 1, 2022 —  Onsite Women’s Health, a leading national provider of breast health services, announces with Whiterabbit.ai and Washington University in St. Louis the results of a longitudinal study of breast density using artificial intelligence (AI). RSNA (Radiological Society of North America) accepted the scientific abstract submitted by researchers from Onsite, Whiterabbit and Washington University in St. Louis for an oral presentation, titled: Artificial Intelligence and Consistency in Patient Care: A Large-Scale, Longitudinal Study of Breast Density Assessment at the 108th Scientific Assembly and Annual Meeting (Date/Time of Session: 11/28/2022 1:30-2:30 pm CT). 

“Higher density breast tissue on mammograms means higher risk for breast cancer,” says Dr. Susan Holley, clinical director of Onsite Women’s Health and presenter of the abstract. “Therefore, breast density is an important variable to get right. We wanted to know if an AI tool could help us be right more often, over the long-term.” 

“We are eager to share the findings of this large-scale retrospective study as it reveals fascinating trends about the assessment of breast density over time by radiologists and our AI software, WRDensity. We believe the consistent assessment of breast density is vital to more effective patient management that moves us towards the goal of precision medicine. I’m enthusiastic that new technologies may make a difference in this noble endeavor,” says Jason Su, Whiterabbit’s co-founder and chief technology officer. “We are grateful to have been able to partner with Onsite and Washington University in St. Louis to conduct this study. Their interest in our AI tool and engagement with us has and will continue to be critical to its ongoing development.” 

The team hopes to expand upon this work to explore implications for supplemental screening, and how longitudinal changes in breast density might further inform our understanding of breast cancer risk. 

“The diversity of our research team with representation from real world practice, industry, and academic researchers allows us to pursue really exciting and clinically relevant questions,” concludes Aimilia Gastounioti, assistant professor of Radiology and director of the Breast Image Computing Lab at Washington University in St. Louis. “The advent of AI is poised to change the delivery of health care dramatically in the near future. With academic researchers, physicians and industry partners working hand-in-hand, we can bring all our strengths together to look at questions that have big implications for breast imaging and patient care.” 

For more information: http://www.onsitewomenshealth.com, 

Find more RSNA22 coverage here


Related Content

News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
News | FDA

June 25, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...

Time June 25, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
Subscribe Now